Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Survival Analysis | 19 | 2023 | 10248 | 1.420 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 10 | 2023 | 379 | 1.280 |
Why?
|
Proportional Hazards Models | 22 | 2023 | 12344 | 1.230 |
Why?
|
Neoplasms | 28 | 2023 | 21596 | 0.940 |
Why?
|
Survival Rate | 16 | 2023 | 12773 | 0.850 |
Why?
|
Neoplasm Recurrence, Local | 15 | 2022 | 9185 | 0.780 |
Why?
|
Liver Cirrhosis, Biliary | 1 | 2021 | 96 | 0.750 |
Why?
|
Immunotherapy | 5 | 2023 | 4414 | 0.720 |
Why?
|
DNA Mismatch Repair | 7 | 2023 | 424 | 0.720 |
Why?
|
Randomized Controlled Trials as Topic | 11 | 2022 | 9941 | 0.710 |
Why?
|
Sample Size | 5 | 2020 | 844 | 0.700 |
Why?
|
Lung Neoplasms | 19 | 2022 | 13019 | 0.620 |
Why?
|
Research Design | 8 | 2020 | 5979 | 0.620 |
Why?
|
Germ-Line Mutation | 11 | 2023 | 1786 | 0.610 |
Why?
|
Colorectal Neoplasms | 12 | 2023 | 6754 | 0.600 |
Why?
|
Endpoint Determination | 4 | 2019 | 600 | 0.590 |
Why?
|
Insurance Claim Review | 2 | 2018 | 720 | 0.590 |
Why?
|
Kaplan-Meier Estimate | 9 | 2020 | 6534 | 0.570 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 839 | 0.560 |
Why?
|
Drug Therapy | 2 | 2015 | 497 | 0.530 |
Why?
|
Axilla | 1 | 2018 | 588 | 0.520 |
Why?
|
Breast Neoplasms | 22 | 2022 | 20774 | 0.520 |
Why?
|
Clinical Trials as Topic | 5 | 2021 | 7901 | 0.520 |
Why?
|
Genetic Testing | 6 | 2021 | 3439 | 0.500 |
Why?
|
Spinal Curvatures | 1 | 2014 | 66 | 0.450 |
Why?
|
Natural Language Processing | 1 | 2021 | 1035 | 0.450 |
Why?
|
Braces | 1 | 2014 | 135 | 0.450 |
Why?
|
Lymph Node Excision | 1 | 2018 | 1248 | 0.400 |
Why?
|
Statistics as Topic | 1 | 2018 | 2372 | 0.400 |
Why?
|
Erythropoietin | 7 | 2016 | 724 | 0.400 |
Why?
|
Humans | 152 | 2023 | 742088 | 0.390 |
Why?
|
Electronic Health Records | 5 | 2022 | 4440 | 0.390 |
Why?
|
Terminal Care | 5 | 2023 | 1688 | 0.390 |
Why?
|
Data Interpretation, Statistical | 5 | 2018 | 2714 | 0.380 |
Why?
|
Medical Oncology | 7 | 2022 | 2235 | 0.380 |
Why?
|
Anemia | 8 | 2016 | 1499 | 0.370 |
Why?
|
Models, Statistical | 8 | 2023 | 5100 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 5 | 2018 | 5171 | 0.330 |
Why?
|
Hematinics | 7 | 2016 | 281 | 0.330 |
Why?
|
Myelodysplastic Syndromes | 2 | 2016 | 1351 | 0.310 |
Why?
|
Life Expectancy | 3 | 2020 | 1183 | 0.310 |
Why?
|
Time Factors | 12 | 2023 | 40054 | 0.280 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3070 | 0.270 |
Why?
|
Hematologic Neoplasms | 3 | 2023 | 1820 | 0.270 |
Why?
|
Aged | 66 | 2023 | 162944 | 0.260 |
Why?
|
Skin Neoplasms | 3 | 2023 | 5662 | 0.260 |
Why?
|
Risk Assessment | 13 | 2021 | 23320 | 0.260 |
Why?
|
Female | 91 | 2023 | 379592 | 0.260 |
Why?
|
Algorithms | 5 | 2022 | 13853 | 0.250 |
Why?
|
Computer Simulation | 8 | 2023 | 6191 | 0.240 |
Why?
|
Urologic Neoplasms | 2 | 2019 | 316 | 0.240 |
Why?
|
Middle Aged | 71 | 2023 | 213127 | 0.240 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2020 | 570 | 0.240 |
Why?
|
Male | 81 | 2023 | 349538 | 0.230 |
Why?
|
Databases, Factual | 5 | 2022 | 7716 | 0.230 |
Why?
|
Parents | 3 | 2022 | 3387 | 0.230 |
Why?
|
Simian immunodeficiency virus | 2 | 2020 | 846 | 0.230 |
Why?
|
Models, Genetic | 5 | 2021 | 3493 | 0.220 |
Why?
|
Paclitaxel | 3 | 2018 | 1707 | 0.220 |
Why?
|
Hospice Care | 2 | 2023 | 671 | 0.220 |
Why?
|
Melanoma | 2 | 2018 | 5462 | 0.220 |
Why?
|
Ventricular Dysfunction, Left | 5 | 2011 | 2059 | 0.210 |
Why?
|
Treatment Outcome | 22 | 2020 | 62966 | 0.210 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3611 | 0.210 |
Why?
|
HIV Infections | 8 | 2023 | 16678 | 0.210 |
Why?
|
Health Care Costs | 3 | 2021 | 3203 | 0.210 |
Why?
|
DNA Glycosylases | 2 | 2020 | 128 | 0.210 |
Why?
|
Risk | 3 | 2017 | 9679 | 0.210 |
Why?
|
Palliative Care | 7 | 2023 | 3478 | 0.200 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2023 | 339 | 0.200 |
Why?
|
AIDS Dementia Complex | 2 | 2012 | 152 | 0.190 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2023 | 241 | 0.190 |
Why?
|
Microsatellite Instability | 2 | 2023 | 678 | 0.190 |
Why?
|
Endometrial Neoplasms | 2 | 2020 | 1351 | 0.190 |
Why?
|
Hospitalization | 11 | 2022 | 10232 | 0.190 |
Why?
|
Taxoids | 3 | 2018 | 665 | 0.190 |
Why?
|
ROC Curve | 6 | 2020 | 3528 | 0.190 |
Why?
|
Frail Elderly | 2 | 2023 | 691 | 0.180 |
Why?
|
Empirical Research | 1 | 2020 | 120 | 0.180 |
Why?
|
Polymorphism, Genetic | 1 | 2011 | 4328 | 0.180 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 2 | 2018 | 947 | 0.180 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2020 | 159 | 0.180 |
Why?
|
Genes, APC | 1 | 2020 | 159 | 0.180 |
Why?
|
Patient Preference | 2 | 2019 | 886 | 0.180 |
Why?
|
Clinical Coding | 2 | 2018 | 171 | 0.180 |
Why?
|
Vascular System Injuries | 1 | 2023 | 250 | 0.180 |
Why?
|
Prognosis | 17 | 2022 | 29010 | 0.170 |
Why?
|
Pancreatic Neoplasms | 3 | 2021 | 5249 | 0.170 |
Why?
|
Models, Biological | 2 | 2017 | 9581 | 0.170 |
Why?
|
MutS Homolog 2 Protein | 4 | 2023 | 200 | 0.170 |
Why?
|
Quinolines | 2 | 2016 | 719 | 0.160 |
Why?
|
Jews | 1 | 2020 | 385 | 0.160 |
Why?
|
Medicare | 7 | 2022 | 6532 | 0.160 |
Why?
|
Selection Bias | 1 | 2020 | 369 | 0.160 |
Why?
|
Geriatric Assessment | 2 | 2023 | 1369 | 0.160 |
Why?
|
Receptors, KIR3DL1 | 1 | 2017 | 22 | 0.150 |
Why?
|
Hemoglobins | 3 | 2016 | 1532 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 6 | 2022 | 17400 | 0.150 |
Why?
|
HIV Seronegativity | 1 | 2018 | 211 | 0.150 |
Why?
|
Data Display | 1 | 2018 | 182 | 0.150 |
Why?
|
Lymph Nodes | 2 | 2020 | 3465 | 0.150 |
Why?
|
Quality of Life | 7 | 2023 | 12730 | 0.150 |
Why?
|
Area Under Curve | 4 | 2020 | 1653 | 0.150 |
Why?
|
Neoplasm Staging | 7 | 2021 | 11001 | 0.150 |
Why?
|
Myocardial Infarction | 7 | 2011 | 11690 | 0.150 |
Why?
|
Time-Lapse Imaging | 1 | 2018 | 195 | 0.150 |
Why?
|
Genetic Counseling | 1 | 2021 | 600 | 0.150 |
Why?
|
Nitrites | 1 | 2017 | 160 | 0.150 |
Why?
|
Kidney Diseases | 4 | 2011 | 2145 | 0.140 |
Why?
|
Myocardial Contraction | 3 | 2011 | 1585 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2023 | 3497 | 0.140 |
Why?
|
Epoetin Alfa | 1 | 2016 | 83 | 0.140 |
Why?
|
Sepsis | 1 | 2011 | 2589 | 0.140 |
Why?
|
Attitude to Death | 1 | 2019 | 382 | 0.140 |
Why?
|
Radiosurgery | 2 | 2016 | 1309 | 0.140 |
Why?
|
Severity of Illness Index | 1 | 2014 | 15530 | 0.140 |
Why?
|
BRCA2 Protein | 1 | 2021 | 790 | 0.140 |
Why?
|
Homosexuality, Male | 3 | 2019 | 1238 | 0.140 |
Why?
|
Models, Theoretical | 3 | 2020 | 3584 | 0.140 |
Why?
|
Advance Care Planning | 1 | 2023 | 660 | 0.140 |
Why?
|
Antineoplastic Agents | 7 | 2018 | 13655 | 0.140 |
Why?
|
Monte Carlo Method | 1 | 2021 | 1254 | 0.130 |
Why?
|
Breast | 2 | 2022 | 1958 | 0.130 |
Why?
|
Adult | 37 | 2023 | 213712 | 0.130 |
Why?
|
Carboplatin | 1 | 2018 | 799 | 0.130 |
Why?
|
Heart Failure | 7 | 2016 | 10856 | 0.130 |
Why?
|
HIV | 2 | 2023 | 1600 | 0.130 |
Why?
|
Kidney Failure, Chronic | 4 | 2011 | 2536 | 0.130 |
Why?
|
Cardiac Resynchronization Therapy | 2 | 2011 | 532 | 0.130 |
Why?
|
Aged, 80 and over | 20 | 2022 | 57683 | 0.130 |
Why?
|
Anus Neoplasms | 1 | 2019 | 332 | 0.130 |
Why?
|
United States | 17 | 2022 | 69693 | 0.130 |
Why?
|
BRCA1 Protein | 1 | 2021 | 1145 | 0.130 |
Why?
|
Central Nervous System Neoplasms | 1 | 2023 | 895 | 0.120 |
Why?
|
Hyperemia | 1 | 2016 | 224 | 0.120 |
Why?
|
Leukocyte Count | 1 | 2018 | 1583 | 0.120 |
Why?
|
Solitary Pulmonary Nodule | 2 | 2008 | 265 | 0.120 |
Why?
|
Propensity Score | 5 | 2023 | 1771 | 0.120 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1340 | 0.120 |
Why?
|
Patient Care Management | 1 | 2017 | 306 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2019 | 8621 | 0.120 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2019 | 1769 | 0.120 |
Why?
|
Tumor Escape | 1 | 2017 | 349 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2020 | 761 | 0.120 |
Why?
|
Economics | 1 | 2014 | 146 | 0.120 |
Why?
|
International Classification of Diseases | 1 | 2019 | 865 | 0.110 |
Why?
|
Mastectomy | 2 | 2019 | 1789 | 0.110 |
Why?
|
Risk Factors | 17 | 2023 | 72145 | 0.110 |
Why?
|
Hepatitis B | 1 | 2019 | 695 | 0.110 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2018 | 701 | 0.110 |
Why?
|
Cranial Irradiation | 1 | 2016 | 401 | 0.110 |
Why?
|
Fatigue | 1 | 2020 | 1526 | 0.110 |
Why?
|
Receptors, Estrogen | 2 | 2018 | 2186 | 0.110 |
Why?
|
Standard of Care | 1 | 2016 | 562 | 0.110 |
Why?
|
Death, Sudden, Cardiac | 2 | 2011 | 1541 | 0.110 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2885 | 0.100 |
Why?
|
Retrospective Studies | 18 | 2023 | 77098 | 0.100 |
Why?
|
Virus Replication | 1 | 2020 | 2531 | 0.100 |
Why?
|
Cohort Studies | 13 | 2022 | 40450 | 0.100 |
Why?
|
Cardiovascular Diseases | 6 | 2017 | 15108 | 0.100 |
Why?
|
Neuroblastoma | 1 | 2019 | 1225 | 0.100 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2012 | 11695 | 0.100 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.100 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2017 | 1038 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 814 | 0.100 |
Why?
|
Physician-Patient Relations | 2 | 2021 | 3215 | 0.100 |
Why?
|
Dibenzocycloheptenes | 1 | 2010 | 27 | 0.100 |
Why?
|
Prospective Studies | 15 | 2021 | 53187 | 0.100 |
Why?
|
Biostatistics | 1 | 2012 | 160 | 0.100 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2017 | 1366 | 0.100 |
Why?
|
Drug Utilization | 1 | 2017 | 1181 | 0.100 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 774 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1668 | 0.090 |
Why?
|
APACHE | 1 | 2011 | 277 | 0.090 |
Why?
|
T-Lymphocyte Subsets | 1 | 2018 | 1837 | 0.090 |
Why?
|
Spinal Diseases | 1 | 2015 | 538 | 0.090 |
Why?
|
SEER Program | 3 | 2022 | 1507 | 0.090 |
Why?
|
Patient Education as Topic | 1 | 2020 | 2275 | 0.090 |
Why?
|
Death | 3 | 2023 | 675 | 0.090 |
Why?
|
Carcinoembryonic Antigen | 2 | 2008 | 347 | 0.090 |
Why?
|
Interleukin-6 | 3 | 2023 | 3199 | 0.090 |
Why?
|
Rectal Neoplasms | 1 | 2019 | 1195 | 0.090 |
Why?
|
Blood Cells | 1 | 2012 | 309 | 0.090 |
Why?
|
Japan | 2 | 2011 | 1360 | 0.090 |
Why?
|
Adenoma | 1 | 2020 | 2168 | 0.090 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2017 | 1820 | 0.090 |
Why?
|
Thalidomide | 2 | 2011 | 888 | 0.090 |
Why?
|
Heterozygote | 3 | 2022 | 2790 | 0.090 |
Why?
|
Decision Making | 2 | 2020 | 3869 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2017 | 1101 | 0.080 |
Why?
|
Polydeoxyribonucleotides | 1 | 2010 | 127 | 0.080 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2010 | 453 | 0.080 |
Why?
|
Follow-Up Studies | 9 | 2018 | 39004 | 0.080 |
Why?
|
Glomerular Filtration Rate | 3 | 2011 | 2167 | 0.080 |
Why?
|
Spinal Fractures | 1 | 2015 | 698 | 0.080 |
Why?
|
Logistic Models | 7 | 2019 | 13403 | 0.080 |
Why?
|
Ventricular Fibrillation | 1 | 2011 | 538 | 0.080 |
Why?
|
Incidence | 5 | 2019 | 20928 | 0.080 |
Why?
|
Killer Cells, Natural | 1 | 2017 | 2133 | 0.080 |
Why?
|
DNA Copy Number Variations | 1 | 2017 | 1940 | 0.080 |
Why?
|
Spinal Neoplasms | 1 | 2015 | 759 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 980 | 0.080 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2012 | 2195 | 0.080 |
Why?
|
Hepatic Veno-Occlusive Disease | 1 | 2010 | 220 | 0.080 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 2008 | 134 | 0.080 |
Why?
|
Joint Instability | 1 | 2015 | 792 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15056 | 0.080 |
Why?
|
Attitude of Health Personnel | 1 | 2021 | 3839 | 0.080 |
Why?
|
Granuloma, Respiratory Tract | 1 | 2007 | 8 | 0.080 |
Why?
|
Dexamethasone | 2 | 2011 | 1949 | 0.070 |
Why?
|
Multiple Organ Failure | 1 | 2010 | 389 | 0.070 |
Why?
|
Minoxidil | 1 | 1987 | 33 | 0.070 |
Why?
|
Laparoscopy | 1 | 2019 | 2121 | 0.070 |
Why?
|
Multiple Myeloma | 3 | 2023 | 5169 | 0.070 |
Why?
|
Reproducibility of Results | 7 | 2019 | 19862 | 0.070 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2007 | 76 | 0.070 |
Why?
|
Lung Diseases | 2 | 2007 | 1884 | 0.070 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1379 | 0.070 |
Why?
|
Young Adult | 11 | 2023 | 56350 | 0.070 |
Why?
|
Salvage Therapy | 3 | 2015 | 1269 | 0.070 |
Why?
|
Tetrazoles | 2 | 2010 | 835 | 0.070 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.070 |
Why?
|
Troponin T | 1 | 2011 | 749 | 0.070 |
Why?
|
Aldosterone | 1 | 2011 | 876 | 0.070 |
Why?
|
Antibodies, Monoclonal | 2 | 2016 | 9274 | 0.070 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2014 | 987 | 0.070 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2011 | 859 | 0.070 |
Why?
|
Physicians | 2 | 2021 | 4554 | 0.070 |
Why?
|
Cancer Care Facilities | 2 | 2021 | 401 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2010 | 820 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 1239 | 0.060 |
Why?
|
Thymoma | 1 | 2006 | 186 | 0.060 |
Why?
|
Longitudinal Studies | 3 | 2018 | 13921 | 0.060 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2019 | 4029 | 0.060 |
Why?
|
Accidents, Traffic | 1 | 2010 | 819 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11472 | 0.060 |
Why?
|
RNA, Viral | 3 | 2020 | 2899 | 0.060 |
Why?
|
Anthracyclines | 1 | 2006 | 288 | 0.060 |
Why?
|
Recurrence | 4 | 2023 | 8333 | 0.060 |
Why?
|
Diabetic Nephropathies | 1 | 2011 | 983 | 0.060 |
Why?
|
Viral Load | 3 | 2020 | 3292 | 0.060 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 1517 | 0.060 |
Why?
|
Bone Marrow Cells | 1 | 2012 | 2513 | 0.060 |
Why?
|
Age Factors | 5 | 2021 | 18355 | 0.060 |
Why?
|
Thymus Neoplasms | 1 | 2006 | 268 | 0.060 |
Why?
|
Macaca mulatta | 3 | 2020 | 2378 | 0.060 |
Why?
|
Mucin-1 | 1 | 2008 | 543 | 0.060 |
Why?
|
Diabetes Complications | 1 | 2011 | 1359 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2450 | 0.060 |
Why?
|
Benzimidazoles | 1 | 2008 | 848 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4823 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2011 | 1573 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2010 | 1224 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2011 | 9410 | 0.060 |
Why?
|
Alopecia | 1 | 1987 | 381 | 0.060 |
Why?
|
Intensive Care Units | 2 | 2019 | 3679 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 2018 | 4250 | 0.050 |
Why?
|
Caregivers | 1 | 2014 | 2074 | 0.050 |
Why?
|
Monocytes | 1 | 2012 | 2593 | 0.050 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 2015 | 4839 | 0.050 |
Why?
|
Communication | 3 | 2022 | 3728 | 0.050 |
Why?
|
Child | 8 | 2023 | 77478 | 0.050 |
Why?
|
Heart Atria | 1 | 2008 | 1348 | 0.050 |
Why?
|
Tachycardia, Ventricular | 1 | 2011 | 1272 | 0.050 |
Why?
|
Mastectomy, Segmental | 2 | 2018 | 955 | 0.050 |
Why?
|
Health Status Indicators | 2 | 2018 | 968 | 0.050 |
Why?
|
Receptors, Progesterone | 2 | 2018 | 1097 | 0.050 |
Why?
|
Learning | 1 | 2011 | 1705 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 5 | 2008 | 20086 | 0.050 |
Why?
|
Neuropsychological Tests | 2 | 2012 | 6974 | 0.050 |
Why?
|
Double-Blind Method | 5 | 2016 | 12017 | 0.050 |
Why?
|
Marital Status | 1 | 2023 | 437 | 0.050 |
Why?
|
Thymus Gland | 1 | 2006 | 1264 | 0.050 |
Why?
|
Critical Care | 1 | 2014 | 2640 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2906 | 0.050 |
Why?
|
Hypertension | 3 | 2011 | 8455 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2012 | 2183 | 0.050 |
Why?
|
Sex Factors | 3 | 2021 | 10392 | 0.050 |
Why?
|
Sulfonamides | 2 | 2023 | 1932 | 0.050 |
Why?
|
Flow Cytometry | 1 | 2012 | 5975 | 0.050 |
Why?
|
Stroke Volume | 2 | 2011 | 4983 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2005 | 623 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 24913 | 0.050 |
Why?
|
Attention | 1 | 2011 | 2396 | 0.050 |
Why?
|
Adolescent | 6 | 2023 | 85649 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2023 | 707 | 0.050 |
Why?
|
Heredity | 1 | 2021 | 154 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2016 | 4369 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2023 | 689 | 0.050 |
Why?
|
Gene Products, nef | 1 | 2020 | 110 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2023 | 1003 | 0.050 |
Why?
|
Multimedia | 1 | 2020 | 77 | 0.050 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2009 | 1052 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2010 | 2156 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2013 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2023 | 1155 | 0.040 |
Why?
|
Receptor, erbB-2 | 3 | 2016 | 2410 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 2 | 2018 | 2557 | 0.040 |
Why?
|
CD4-CD8 Ratio | 1 | 2018 | 112 | 0.040 |
Why?
|
Feeding Behavior | 1 | 2011 | 3187 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5095 | 0.040 |
Why?
|
Therapies, Investigational | 1 | 2019 | 111 | 0.040 |
Why?
|
Diabetes Mellitus | 2 | 2021 | 5724 | 0.040 |
Why?
|
Sensitivity and Specificity | 4 | 2020 | 14720 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2007 | 4742 | 0.040 |
Why?
|
Telemedicine | 2 | 2021 | 2853 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2016 | 8829 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3920 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 681 | 0.040 |
Why?
|
Ventricular Function, Left | 1 | 2010 | 3656 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 5955 | 0.040 |
Why?
|
Bone Neoplasms | 2 | 2007 | 2522 | 0.040 |
Why?
|
Defibrillators, Implantable | 3 | 2011 | 1440 | 0.040 |
Why?
|
Health Status | 1 | 2011 | 4030 | 0.040 |
Why?
|
Fallopian Tube Neoplasms | 1 | 2020 | 324 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1661 | 0.040 |
Why?
|
Lung | 1 | 2016 | 9826 | 0.040 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2020 | 334 | 0.040 |
Why?
|
Germ Cells | 1 | 2021 | 628 | 0.040 |
Why?
|
Breast Implantation | 1 | 2019 | 218 | 0.040 |
Why?
|
Genes, p16 | 1 | 2017 | 157 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2017 | 287 | 0.040 |
Why?
|
Causality | 1 | 2023 | 1265 | 0.030 |
Why?
|
Hospices | 1 | 2019 | 264 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2017 | 188 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2016 | 157 | 0.030 |
Why?
|
Indazoles | 1 | 2017 | 287 | 0.030 |
Why?
|
Lymphoid Tissue | 1 | 2017 | 455 | 0.030 |
Why?
|
Medical History Taking | 1 | 2019 | 783 | 0.030 |
Why?
|
Observation | 1 | 2017 | 312 | 0.030 |
Why?
|
Albuterol | 1 | 2016 | 208 | 0.030 |
Why?
|
Cytogenetics | 1 | 2016 | 203 | 0.030 |
Why?
|
Phenotype | 3 | 2021 | 16331 | 0.030 |
Why?
|
Herpesviridae Infections | 1 | 2017 | 277 | 0.030 |
Why?
|
Administration, Oral | 1 | 2023 | 3913 | 0.030 |
Why?
|
Multivariate Analysis | 4 | 2011 | 12242 | 0.030 |
Why?
|
Penetrance | 1 | 2017 | 380 | 0.030 |
Why?
|
Ultrasonography | 3 | 2016 | 5978 | 0.030 |
Why?
|
Adrenergic beta-Agonists | 1 | 2016 | 346 | 0.030 |
Why?
|
Stochastic Processes | 1 | 2015 | 344 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 2007 | 3691 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11039 | 0.030 |
Why?
|
Prevalence | 1 | 2011 | 15194 | 0.030 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2007 | 2229 | 0.030 |
Why?
|
Aging | 3 | 2021 | 8626 | 0.030 |
Why?
|
Random Allocation | 1 | 2018 | 2425 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2019 | 921 | 0.030 |
Why?
|
Case-Control Studies | 4 | 2018 | 21719 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8077 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 2016 | 1104 | 0.030 |
Why?
|
Echocardiography | 3 | 2011 | 5097 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 617 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2018 | 820 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2022 | 1760 | 0.030 |
Why?
|
Marijuana Abuse | 1 | 2017 | 402 | 0.030 |
Why?
|
Regression Analysis | 2 | 2017 | 6452 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3587 | 0.030 |
Why?
|
Liver Diseases | 1 | 2021 | 1252 | 0.030 |
Why?
|
Cause of Death | 2 | 2016 | 3571 | 0.030 |
Why?
|
Diphosphonates | 1 | 2018 | 625 | 0.030 |
Why?
|
Spinal Cord Compression | 1 | 2015 | 235 | 0.030 |
Why?
|
Pedigree | 1 | 2021 | 4646 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 502 | 0.030 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2021 | 1872 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1368 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 780 | 0.030 |
Why?
|
Survivors | 1 | 2023 | 2286 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 608 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6259 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.030 |
Why?
|
Stroke | 2 | 2011 | 9963 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2010 | 5425 | 0.030 |
Why?
|
Anti-Asthmatic Agents | 1 | 2016 | 533 | 0.030 |
Why?
|
Overweight | 1 | 2023 | 2366 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2016 | 693 | 0.030 |
Why?
|
Adenocarcinoma | 2 | 2007 | 6347 | 0.020 |
Why?
|
Point Mutation | 1 | 2017 | 1624 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2017 | 10472 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2011 | 6454 | 0.020 |
Why?
|
Disease Progression | 4 | 2010 | 13256 | 0.020 |
Why?
|
Back Pain | 1 | 2015 | 545 | 0.020 |
Why?
|
Abbreviated Injury Scale | 1 | 2010 | 51 | 0.020 |
Why?
|
Fumarates | 1 | 2011 | 132 | 0.020 |
Why?
|
Analog-Digital Conversion | 1 | 2010 | 23 | 0.020 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2021 | 1631 | 0.020 |
Why?
|
Daunorubicin | 1 | 2010 | 149 | 0.020 |
Why?
|
Cytokines | 2 | 2017 | 7317 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2005 | 5163 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 617 | 0.020 |
Why?
|
Motivation | 1 | 2019 | 1968 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2017 | 9639 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2020 | 7873 | 0.020 |
Why?
|
Antigens, CD | 1 | 2020 | 4024 | 0.020 |
Why?
|
Mammaplasty | 1 | 2019 | 1195 | 0.020 |
Why?
|
Losartan | 1 | 2011 | 298 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2022 | 3527 | 0.020 |
Why?
|
Injections, Subcutaneous | 1 | 2010 | 664 | 0.020 |
Why?
|
Systole | 1 | 2011 | 956 | 0.020 |
Why?
|
Endometriosis | 1 | 1997 | 834 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 2020 | 2684 | 0.020 |
Why?
|
Boston | 1 | 2021 | 9305 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2876 | 0.020 |
Why?
|
Amides | 1 | 2011 | 458 | 0.020 |
Why?
|
Cell Cycle | 1 | 2017 | 2964 | 0.020 |
Why?
|
Valine | 1 | 2010 | 413 | 0.020 |
Why?
|
Radiotherapy | 1 | 2015 | 1525 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4187 | 0.020 |
Why?
|
Up-Regulation | 1 | 2017 | 4211 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2020 | 13814 | 0.020 |
Why?
|
Chemokines | 1 | 2012 | 954 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4595 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9846 | 0.020 |
Why?
|
Emotions | 1 | 2019 | 2657 | 0.020 |
Why?
|
Iron | 1 | 2016 | 1773 | 0.020 |
Why?
|
Atrial Function, Left | 1 | 2008 | 173 | 0.020 |
Why?
|
Linear Models | 2 | 2008 | 5948 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4379 | 0.020 |
Why?
|
Comorbidity | 1 | 2021 | 10372 | 0.020 |
Why?
|
Bone and Bones | 1 | 2018 | 2575 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3038 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2010 | 1013 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3391 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2016 | 6608 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4801 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2970 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2022 | 3151 | 0.020 |
Why?
|
Resuscitation | 1 | 2011 | 657 | 0.020 |
Why?
|
Pediatrics | 1 | 2021 | 3462 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2017 | 2842 | 0.020 |
Why?
|
Population Groups | 1 | 2007 | 208 | 0.020 |
Why?
|
Demography | 1 | 2011 | 1650 | 0.020 |
Why?
|
Chronic Disease | 2 | 2011 | 9144 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2948 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 694 | 0.020 |
Why?
|
Proteinuria | 1 | 2009 | 657 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2253 | 0.020 |
Why?
|
Motion | 1 | 2010 | 797 | 0.020 |
Why?
|
Placebos | 1 | 2010 | 1677 | 0.020 |
Why?
|
Asia | 1 | 2007 | 607 | 0.020 |
Why?
|
Canada | 1 | 2011 | 2061 | 0.020 |
Why?
|
Macaca | 1 | 1987 | 440 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2016 | 1831 | 0.020 |
Why?
|
Body Mass Index | 1 | 2023 | 12695 | 0.020 |
Why?
|
Pyrimidines | 1 | 2017 | 2933 | 0.020 |
Why?
|
Papillomavirus Infections | 1 | 2017 | 1585 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2638 | 0.020 |
Why?
|
Aortic Valve Stenosis | 1 | 2017 | 1941 | 0.020 |
Why?
|
Administration, Topical | 1 | 1987 | 688 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2011 | 1123 | 0.020 |
Why?
|
Video Recording | 1 | 2010 | 944 | 0.020 |
Why?
|
Remission Induction | 1 | 2010 | 2384 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2011 | 1811 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1684 | 0.020 |
Why?
|
Cost of Illness | 1 | 2014 | 1852 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3507 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 2009 | 1538 | 0.020 |
Why?
|
Europe | 1 | 2011 | 3339 | 0.020 |
Why?
|
Biphenyl Compounds | 1 | 2008 | 914 | 0.010 |
Why?
|
Scalp | 1 | 1987 | 380 | 0.010 |
Why?
|
Premenopause | 1 | 2008 | 1033 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3510 | 0.010 |
Why?
|
Genotype | 1 | 2018 | 12946 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2011 | 2211 | 0.010 |
Why?
|
Hair | 1 | 1987 | 483 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10578 | 0.010 |
Why?
|
Child, Preschool | 2 | 2019 | 40955 | 0.010 |
Why?
|
Indoles | 1 | 2011 | 1834 | 0.010 |
Why?
|
Clinical Competence | 1 | 2018 | 4681 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5851 | 0.010 |
Why?
|
Health Expenditures | 1 | 2014 | 2346 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 8969 | 0.010 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2043 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2007 | 719 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6365 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2009 | 4929 | 0.010 |
Why?
|
Hepatitis C | 1 | 2011 | 1582 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2006 | 1640 | 0.010 |
Why?
|
HIV-1 | 1 | 2018 | 6934 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
Animals | 4 | 2020 | 168561 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2006 | 2236 | 0.010 |
Why?
|
Depression | 1 | 2020 | 7733 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2014 | 7770 | 0.010 |
Why?
|
Menopause | 1 | 2008 | 1621 | 0.010 |
Why?
|
Doxorubicin | 1 | 2006 | 2215 | 0.010 |
Why?
|
Radiography, Interventional | 1 | 2006 | 1095 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2011 | 3801 | 0.010 |
Why?
|
Proteomics | 1 | 2012 | 3618 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2658 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2006 | 3471 | 0.010 |
Why?
|
Electrocardiography | 1 | 2011 | 6440 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2010 | 10943 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15994 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2005 | 2906 | 0.010 |
Why?
|
Opioid-Related Disorders | 1 | 2011 | 2062 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6249 | 0.010 |
Why?
|
Drug Implants | 1 | 1997 | 243 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3766 | 0.010 |
Why?
|
Blood Pressure | 1 | 2011 | 8541 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 6722 | 0.010 |
Why?
|
Mutation | 1 | 2018 | 29717 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12958 | 0.010 |
Why?
|
Uterus | 1 | 1997 | 710 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 25575 | 0.010 |
Why?
|
Brain | 1 | 2016 | 26343 | 0.010 |
Why?
|
Estradiol | 1 | 1997 | 2021 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2005 | 4249 | 0.010 |
Why?
|
Signal Transduction | 1 | 2012 | 23387 | 0.010 |
Why?
|
Infant | 1 | 2010 | 35070 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1997 | 15244 | 0.000 |
Why?
|